Results 1 to 10 of about 272,989 (375)

Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials. [PDF]

J Viral Hepat, 2021
Sustained virologic response at posttreatment Week 12 (SVR12) is the widely accepted efficacy endpoint for direct‐acting antiviral agents. Those with hepatitis C virus (HCV) are presenting younger with milder liver disease, potentially reducing need for ...
Gane E, de Ledinghen V, Dylla DE, Rizzardini G, Shiffman ML, Barclay ST, Calleja JL, Xue Z, Burroughs M, Gutierrez JA.   +9 more
europepmc   +2 more sources

Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response. [PDF]

Hepatol Commun, 2021
Hepatocellular carcinoma (HCC) can de novo develop in patients with chronic hepatitis C even after the achievement of sustained virologic response (SVR).
Toyoda H, Hiraoka A, Uojima H, Nozaki A, Shimada N, Takaguchi K, Abe H, Atsukawa M, Matsuura K, Ishikawa T, Mikami S, Watanabe T, Itobayashi E, Tsuji K, Arai T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Okubo T, Ehira T, Kumada T, Tanaka J.   +22 more
europepmc   +2 more sources

Nachbetreuung von PatientInnen mit „sustained virologic response“ [PDF]

Journal für Gastroenterologische und Hepatologische Erkrankungen, 2020
Da die Therapie der chronischen Hepatitis C aufgrund der neuen direkt antiviral wirkenden Therapeutika („direct-acting antivirals“, DAA) aus virologischer Sicht bei nahezu allen PatientInnen zur nachhaltigen Ausheilung („sustained virologic response ...
G. Semmler, M. Mandorfer
semanticscholar   +2 more sources

Frequency of Sustained Virologic Response in Hepatitis C Positive, Treatment Naïve Patients on Sofosbuvir and Daclatasvir [PDF]

Journal of Gandhara Medical and Dental Sciences, 2023
OBJECTIVES To measure the frequency of sustained virologic response in Hepatitis C positive, treatment naïve patients on Sofosbuvir and Daclatasvir.
Islam Shah, Nayab Munib, Aliena Badshah, Wazir Mohammad   +3 more
doaj   +3 more sources

Treatment predictors of a sustained virologic response in hepatitis B and C [PDF]

Journal of Hepatology, 2008
Treatment predictors are important tools for the management of therapy in patients with chronic hepatitis B and C virus (HBV, HCV) infection. In chronic hepatitis B, several pretreatment parameters have been identified for prediction of virologic response to interferon alfa-based antiviral therapies or treatment with polymerase inhibitors.
Annika Kau, Johannes Vermehren, Christoph Sarrazin   +2 more
openalex   +5 more sources

Durability of Sustained Virologic Response in Chronic Hepatitis C [PDF]

Gut and Liver, 2013
Background/AimsThe aim of this study is to investigate the rate of sustained virologic response (SVR) in chronic hepatitis C patients receiving antiviral treatment.Methods : The files of patients with chronic hepatitis C treated with interferon±ribavirin
Ahmet Danalioglu, Fatih Besisik, Kadir Demir, Fatih Ermis, Filiz Akyuz, Ahmet Uyanikoglu, Binnur Pinarbasi, Sabahattin Kaymakoglu, Yilmaz Cakaloglu   +8 more
doaj   +5 more sources

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir. [PDF]

Cureus, 2023
Hepatitis C, a single-stranded RNA virus officially discovered in 1989, is one of the most known viruses of the Flaviviridae family. Direct-acting antiviral drugs helped revolutionize the management of hepatitis C infection by guaranteeing higher cure rates.
Abi-Saleh SP, Ghazal F, Urtasun Sotil E.
europepmc   +3 more sources

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C [PDF]

Clinical and Molecular Hepatology, 2019
Hepatitis C virus (HCV) infection is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC), and is a leading cause of liver-related deaths worldwide. Recently available direct-acting antiviral agent is very safe and highly effective (
Seong Kyun Na, Byung-Cheol Song
doaj   +2 more sources

The sustained virologic response of nonresponder hepatitis C virus patients with retreatment

Indian Journal of Pathology and Microbiology, 2011
Background: Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment in ...
Sila Cetin Akhan, Erdem Gurel, Murat Sayan   +2 more
doaj   +5 more sources

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis [PDF]

Brazilian Journal of Infectious Diseases, 2010
Background and objectives: Evidence suggests that sustained virologic response to interferon treatment decreases incidence of hepatocellular carcinoma in patients with hepatitis C virus cirrhosis.
Nelson Cheinquer, Hugo Cheinquer, Fernando H. Wolff, Silvia Coelho-Borges   +3 more
doaj   +8 more sources